Evidence map›Paper›PMID 40078053›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2025

The prevalence of peanut-triggered food protein-induced enterocolitis syndrome in a prospective cohort of infants introducing peanut in the first year of life.

Dirk H J Verhoeven, Geertje Hofstra, Joyce Faber, Olga Benjamin-van Aalst, Mijke Breukels, Tom Hendriks, Roy Gerth van Wijk, Hans de Groot

Abstract read
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The prevalence of peanut-triggered food protein-induced enterocolitis syndrome in a prospective cohort of infants introducing peanut in the first year of life.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dirk H J VerhoevenDepartment of Pediatrics, Reinier de Graaf Hospital, Delft, The Netherlands.ORCID https://orcid.org/0009-0004-3599-6888
Geertje HofstraDepartment of Pediatrics, Martini Hospital, Groningen, The Netherlands.
Joyce FaberPediatrics Allergy Treatment Centre, Deventer Hospital, Deventer, The Netherlands.
Olga Benjamin-van AalstDepartment of Pediatrics, Northwest Clinics, Alkmaar, The Netherlands.
Mijke BreukelsDepartment of Pediatrics, Elkerliek Hospital, Helmond, The Netherlands.
Tom HendriksDepartment of Pediatrics, Catharina Hospital, Eindhoven, The Netherlands.
Roy Gerth van WijkSection of Allergology and Clinical Immunology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Hans de GrootDepartment of Pediatrics, Reinier de Graaf Hospital, Delft, The Netherlands.

Funding

Reinier de Graaf Hospital Scientific Board 6218.005
6 · The paper itself

Abstract

backgroundSince the early introduction of peanut to prevent IgE-mediated peanut allergy, other case series have suggested an increased incidence of peanut-triggered Food Protein Induced Enterocolitis Syndrome (FPIES). Data on the prevalence of peanut-induced FPIES in prospective cohorts are lacking.

methodsThe PeanutNL cohort is a prospective cohort that included infants at risk of peanut allergy (n = 706) as well as infants with reactions to peanut at home after early introduction (n = 186). They all introduced peanut before the age of 12 months. Oral food challenges were performed to introduce peanut or to evaluate reactions to peanut at home.

resultsOf the 706 infants that were included for first introduction of peanut, 2 had reactions with a phenotype compatible with FPIES (0.3%). Of the 186 infants with reactions to peanut at home, 6 were diagnosed with FPIES (3.2%). Seven out of 8 cases had ingestions of peanut without reactions at home or during clinical introduction before FPIES became apparent. During a 3-year follow-up, six infants (75%) were shown to be tolerant to peanut before the age of 3 years.

conclusionThe prevalence of challenge-proven peanut-induced FPIES in a Dutch cohort of atopic infants that introduced peanut between the ages of 4 and 11 months is 0.3%. The majority of cases were tolerant to peanut before the age of 3 years. When introducing peanut in the first year of life, physicians should be aware of FPIES reactions, but it should not be a reason to avoid early introduction of peanut.

Indexed as

AllergensArachisDietary ProteinsEnterocolitisPeanut HypersensitivityChild, PreschoolCohort StudiesFemaleFollow-Up StudiesHumansImmunoglobulin EInfantMaleNetherlandsPrevalenceProspective StudiesAllergensDietary ProteinsImmunoglobulin Eearly introductionFPIESinfantspeanut allergyprevention

Identifiers

PMID40078053
PMCPMC11904443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.